Search

Knowledge of the movement patterns and area utilisation of commercially important fish stocks is critical to management. The Eastern Baltic cod Gadus morhua, one of the most commercially and ecologically important stocks in the Baltic Sea, is currently one of the most severely impacted fish stocks in Europe. During the last 2 decades, this stock has experienced drastic decreases in population size, distributional range, individual growth and body condition, all of which may have affected the movements between different areas of the Baltic Sea. In this study, we investigated the seasonal movement patterns of Eastern Baltic cod by re-analysing historical tagging data collected by the countries surrounding the Baltic Sea (1955-1988) and compared historical patterns with contemporary data from a recent international tagging experiment (2016-2019). Our re-analyses of historical data showed the presence of different movement behaviours, i.e. resident or seasonally migratory, with larger distances moved by cod released in the northern and central Baltic areas compared to cod released in the southern Baltic areas. Furthermore, trends from the recent tagging experiment indicate a persistent resident strategy in the southern Baltic area. These findings present additional information on general movement patterns and area utilisation of Eastern Baltic cod that could inform future management actions and aid stock recovery.

In the present review article, the definitions and the most advanced findings within Process Intensification are collected and discussed. The intention is to give the readers the basic concepts, fixing the syllabus, as well as some relevant application examples of a discipline that is well-established and considered a hot topic in the chemical reaction engineering field at present.

The main objective of the Working Group on Biological Parameters (WGBIOP) is to review the status, issues, developments, and quality assurance of biological parameters used in assessment and management. WGBIOP (1) plans workshops, exchanges, and validation studies on a range of biological varia-bles to review the quality of information supplied for stock assessment and improve quality as-surance and training; (2) investigates data availability and develops documentation and methods to improve communication between data collectors and end-users; (3) delivers new and im-proved functionality for the SmartDots platform. Four otolith exchanges and two workshops were completed in 2020–2021 using SmartDots— eight further exchanges are ongoing. Proposed future exchanges and workshops were reviewed and approved. The development of the SmartDots platform proceeded with the inclusion of the maturity, eggs, atresia, fecundity, and larval identification modules into the software version. A live SmartDots tutorial for event coordinators was conducted. Work to further develop quality assurance guidelines—and review national applications of these—progressed. Age and maturity validation studies were reviewed and a new method for prioritizing future validation work was proposed. Progress with the Stock Identification Database (SID) was reviewed, and the potential for creating a WGBIOP library collection and active involvement of WGBIOP in updating FishBase.org data were evaluated. The importance of identifying and documenting links be-tween all relevant databases and document repositories was identified, and a task to address this was initiated. Work on improving the feedback loop between data collectors and stock assessors on the usage and quality of biological parameters in stock assessment continued. Moving forward, WGBIOP aims to continue collaboration with WGALES and WGSMART on the development of the SmartDots platform, encouraging cross-group sharing of skills and ex-perience to optimize results. WGBIOP aims to improve accessibility to its outputs through up-dates to SID and FishBase.org, and the potential creation of a WGBIOP library collection. WGBIOP hopes to improve two-way communication between data collectors and end-users around the quality and utility of biological parameters used in assessment. WGBIOP also aims to amalgamate all validation activities into one coherent workstream., ICES

The main objective of the Working Group on Biological Parameters (WGBIOP) is to review the status, issues, developments, and quality assurance of biological parameters for use in assess-ments and management that are in line with the requirements of end-users. In this final year of the three-year term, WGBIOP operated under challenging circumstances due to COVID-19 measures. The initial action plan was replaced by a more flexible one, where online plenary and subgroup meetings were spread over the year with intersessional work to finalize the proposed deliverables. WGBIOP continued the review of past exchanges and workshops under the remit of the working group. Since 2019, these calibrations on age, maturity, and larvae identification have been carried out in SmartDots, an online platform for sharing images and facilitating the reading of otoliths, staging of gonads, and identification of early life stages. Developments are underway to include an improved calculation of modal age and error matrices in the SmartDots standard report. WGBIOP investigated ways to incorporate error matrices into assessments and studied the effect of this inclusion together with stock assessors. Requests for new exchanges and workshops were reviewed, with a focus on stocks to be bench-marked in the coming years. Issue lists were scrutinized, problems identified, and information provided to stock coordinators via regular channels and through the Stock Identification Data-base (SID). Despite close cooperation with stock assessors and continued efforts, it has not been possible to further streamline the WGBIOP workflow with the benchmark process. This will be addressed with the Advisory Committee. The need for validation studies was stressed by the repeated low levels of agreement between readers of some stocks and recurring issues and recommendations to WGBIOP. Lack of resources is the main obstacle. As a first step for measures to prioritize validation studies, WGBIOP iden-tified precision, trueness, and feasibility of validation methods (as well as the urgency for the assessment). WGBIOP continued investigations into new life-history parameters for integrated assessment and advice in cooperation with end-users (Working Group on Integrative, Physical-biological and Ecosystem Modelling-WGIPEM and Regional Coordination Groups-RCGs). This included a standardization and quality assurance action plan for stomach sampling. Efforts have also been taken to streamline data and workflows across databases and groups. A step has been taken in the standardization of quality assurance procedures at the regional level. Institute-level overviews of methods and quality assurance protocols used for ageing and maturity are now available. Also, a new method for quality grading was developed, tested, and implemented in SmartDots.

Recent literature indicates a potential importance of the gut microbiota for immune mediated diseases. For instance, decreased diversity of commensals or an outgrowth of some bacterial strains, referred to as gut dysbiosis, was recently linked to hypertension, colitis, lupus, rheumatoid arthritis and multiple sclerosis (MS). Studies in experimental autoimmune encephalomyelitis (EAE) as pivotal animal model of MS revealed a potential importance of microbial metabolites, including short-chain fatty acids or tryptophan metabolites. Both metabolites may influence the disease by modulation of the immune system, mainly by inducing regulatory T cells. These studies prompted researchers to investigate the contribution of the gut microbiota and microbial metabolites in the pathogenesis of MS. This review summarizes recent findings on the gut microbiota in MS patients and discusses the potential mechanisms how microbial metabolites may affect neuroinflammation. Many of these studies have been performed in the EAE model and were later reversely translated to humans. We also give a short summary on dietary high-salt effects on microbiota components and discuss the potential relevance of high-salt as a risk factor in MS. This article is protected by copyright. All rights reserved.